Your browser doesn't support javascript.
loading
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
Montanha, Maiara Camotti; Fabrega, Francesc; Howarth, Alice; Cottura, Nicolas; Kinvig, Hannah; Bunglawala, Fazila; Lloyd, Andrew; Denti, Paolo; Waitt, Catriona; Siccardi, Marco.
Afiliación
  • Montanha MC; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Fabrega F; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Howarth A; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Cottura N; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Kinvig H; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Bunglawala F; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Lloyd A; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Waitt C; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK.
  • Siccardi M; Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK. siccardi@liverpool.ac.uk.
Clin Pharmacokinet ; 61(3): 375-386, 2022 03.
Article en En | MEDLINE | ID: mdl-34635995
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Pharmacokinet Año: 2022 Tipo del documento: Article